Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease

Hydroxyurea (HU) is highly effective treatment for sickle cell disease (SCD). While pediatric use of HU is accepted clinical practice, barriers to use may impede its potential benefit.

[1]  Dionne A. Graham,et al.  Thirty‐day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation , 2012, Pediatric blood & cancer.

[2]  Scott T. Miller,et al.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) , 2011, The Lancet.

[3]  C. Thornburg,et al.  Differences in Health-Related Quality of Life in Children With Sickle Cell Disease Receiving Hydroxyurea , 2011, Journal of pediatric hematology/oncology.

[4]  R. Ware,et al.  Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? , 2011, Current opinion in hematology.

[5]  E. Seiber,et al.  Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease , 2011, American journal of hematology.

[6]  M. Beach,et al.  Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease , 2011, American journal of hematology.

[7]  A. Tripathi,et al.  Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea , 2011, Pediatric blood & cancer.

[8]  A. Lajoie,et al.  Facilitators and Barriers to Self-management of Type 2 Diabetes Among Urban African American Adults , 2010, The Diabetes educator.

[9]  J. Panepinto,et al.  Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization , 2010, American journal of hematology.

[10]  Richard D Moore,et al.  Trust in physicians and racial disparities in HIV care. , 2010, AIDS Patients Care and STDs.

[11]  R. Ware.  How I use hydroxyurea to treat young patients with sickle cell anemia. , 2010, Blood.

[12]  R. Ware,et al.  Hydroxyurea for children with sickle cell disease. , 2010, Hematology/oncology clinics of North America.

[13]  Frank H. Galvan,et al.  Conspiracy Beliefs About HIV Are Related to Antiretroviral Treatment Nonadherence Among African American Men With HIV , 2009, Journal of acquired immune deficiency syndromes.

[14]  Dionne A. Graham,et al.  Corticosteroids for acute chest syndrome in children with sickle cell disease: Variation in use and association with length of stay and readmission , 2009, American journal of hematology.

[15]  C. Haywood,et al.  Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network. , 2008, Journal of the National Medical Association.

[16]  B. Pollock,et al.  National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. , 2008, Annals of internal medicine.

[17]  T. Konrad,et al.  Hydroxyurea therapy for sickle cell disease in community‐based practices: A survey of Florida and North Carolina hematologists/oncologists , 2005, American journal of hematology.

[18]  R. Ware,et al.  Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. , 2004, Blood.

[19]  C. Mancuso,et al.  Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. , 2004, Ethnicity & disease.

[20]  C. Pegelow,et al.  Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. , 2003, JAMA.

[21]  M. Steinberg.  Hydroxyurea Treatment for Sickle Cell Disease , 2002, TheScientificWorldJournal.

[22]  E. Vichinsky,et al.  Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease. , 2000, Journal of pediatric hematology/oncology.

[23]  O. Platt,et al.  Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. , 1999, Blood.

[24]  Jeffrey K. Springston,et al.  Mammography adherence and beliefs in a sample of low-income African American women , 1999, International journal of behavioral medicine.

[25]  M L Terrin,et al.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. , 1995, The New England journal of medicine.